Cristina Buricea
Foot & Ankle Surgery · New York, NYNPI 1770900078
Payments from drug & device makers
Across 159 payments — averaging $44.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$2K
- Integra Lifesciences Corporation$1K
- Osteomed LLC$1K
- Amgen$496
- Corcept Therapeutics$240
- Treace Medical Concepts, Inc.$209
- plus $1K from 33 others
What the payments were for
- Travel & lodging$2,68338%
- Food & beverage$4,32762%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 17 | $2,421 |
| Integra Lifesciences Corporation | 55 | $1,158 |
| Osteomed LLC | 6 | $1,042 |
| Amgen(2 entities) | 11 | $496 |
| Corcept Therapeutics | 8 | $240 |
| Treace Medical Concepts, Inc. | 3 | $209 |
| Advanced Oxygen Therapy Inc. | 4 | $176 |
| Lilly USA, LLC | 6 | $143 |
| Johnson & Johnson | 5 | $112 |
| Chiesi USA, Inc. | 4 | $89 |
| Biocomposites Inc | 2 | $85 |
| Polynovo North America LLC | 2 | $67 |
| Medartis Inc. | 2 | $65 |
| Bioventus LLC | 3 | $59 |
| AbbVie | 2 | $48 |
| Orthofix Medical, Inc. | 2 | $47 |
| Paratek Pharmaceuticals, Inc. | 1 | $46 |
| Novo Nordisk | 2 | $45 |
| Tandem Diabetes Care, Inc. | 2 | $40 |
| Organogenesis Inc. | 2 | $38 |
| AstraZeneca | 2 | $34 |
| Madrigal Pharmaceuticals | 1 | $27 |
| Kerecis Limited | 1 | $25 |
| Merck | 1 | $24 |
| Janssen Scientific Affairs, LLC | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Axogen | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Medtronic | 1 | $19 |
| Vifor Pharma, Inc. | 1 | $19 |
| Averitas Pharma Inc. | 1 | $19 |
| KCI USA, Inc. | 1 | $19 |
| Acera Surgical, Inc. | 1 | $19 |
| Nevro Corp. | 1 | $19 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $18 |
| Vertex | 1 | $16 |
| Hydrofera LLC | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Solventum Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Grafix$1,168
- Oasis$1,168
- STRAVIX PL$1,168
- EXT-Other$911
- Versajet$881
- INTEGRA$496
- TEPEZZA$275
- Lapiplasty System$168
- INTEGRA DERMAL REGENERATION TEMPLATE$165
- PRIMATRIX$165
- Topical oxygen chamber for extremities$122
- GRAFIX PL$116
How this compares
$7,010 in reported general payments places this provider in the 75th percentile of 652 foot & ankle surgery providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxepin Hcl | 303 | $35,484 |
| Fluocinonide | 206 | $15,632 |
| Diclofenac Sodium ErDiclofenac Sodium | 111 | $8,987 |
| Clotrimazole | 117 | $6,464 |
| Fluconazole | 60 | $5,683 |
| Naproxen Sodium | 28 | $2,798 |
| Ammonium Lactate | 88 | $2,093 |
| Etodolac | 13 | $1,944 |
| Ciclopirox | 18 | $497 |
| Nystatin | 20 | $418 |
| Diclofenac Sodium | 11 | $55 |
| Meloxicam | 15 | $19 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in New York
- Jonathan DelandNew York$4.1M
- Constantine DemetracopoulosNew York$888K
- Anne JohnsonNew York$815K
- Scott EllisNew York$644K
- John KennedyNew York$613K
- Stuart MogulNew York$131K
- Deena HornNew York$93K
- John DoolanNew York$87K
- Jason SnyderNew York$79K
- Meghan KellyNew York$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.